Silencing cancer cell communication may reduce the growth of tumors

January 30, 2017

In several types of cancer, elevated expression of the chemokine receptor CCR4 in tumors is associated with poor patient outcomes. Communication through CCR4 may be one mechanism that cancer cells use to create a pro-tumor environment that protects tumors from immune system attacks. Antibodies that block CCR4 are currently in clinical trials for treating blood and lymphatic cancers, but these approaches may also effectively target cancers that produce solid tumors.

In this issue of the JCI, a study led by Frances Balkwill at Barts Cancer Institute evaluated whether blocking CCR4 in a mouse model of cancer could counteract the signaling that creates a pro-tumor environment.

In mice with , antibody-mediated inhibition of CCR4 changed the composition of immune cell populations that were present in the tumor microenvironment. The changes were associated with reduced tumor proliferation, suggesting that inhibition of CCR4 had anti-tumor effects.

These results highlight anti-CCR4 antibodies as a potential therapeutic for multiple cancers that are linked to abnormal CCR4 expression, including ovarian cancer, breast cancer, and glioblastoma.

Explore further: Researchers identify new target for cancer immunotherapy

More information: Chiara Berlato et al, A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer, Journal of Clinical Investigation (2017). DOI: 10.1172/JCI82976

Related Stories

Researchers identify new target for cancer immunotherapy

January 17, 2017

Massachusetts General Hospital investigators have found new evidence that the tumor necrosis factor receptor type II (TNFR2) may be a major target for immuno-oncology treatments, which induce a patient's immune system to ...

Estrogen signaling impacted immune response in cancer

October 17, 2016

While the role of estrogen signaling in tumor development is well understood in breast and ovarian cancer, its role in anti-tumor immunity has not been extensively studied. However, new research from The Wistar Institute ...

Recommended for you

Deworming pill may be effective in treating liver cancer

March 30, 2017

Hepatocellular carcinoma (HCC), a cancer associated with underlying liver disease and cirrhosis that often only becomes symptomatic when it is very advanced, is the second leading cause of cancer deaths around the world, ...

Study shows how BPA may affect inflammatory breast cancer

March 29, 2017

The chemical bisphenol A, or BPA, appears to aid the survival of inflammatory breast cancer cells, revealing a potential mechanism for how the disease grows, according to a study led by researchers in the Department of Surgery ...

Gene research gives new insight into pancreatic cancer

March 29, 2017

One reason pancreatic cancer has a particularly low survival rate is the difficulty in getting drugs to the tumour, but new knowledge of how pancreatic cancer cells invade neighbouring cells could change that.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.